Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

In this page

Clinical Trial

NCT00481546 Active, Not recruiting
LCA

Phase I Trial of Gene Vector to Patients with Retinal Disease due toRPE65 mutations

Phase 1
Interventional

Disease

Disease type

Paediatric clinical trials

Orphan drug recognition

NA

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

01/07/2007

Closing date

01/06/2026

Inclusion criteria :

More

Exclusion criteria :

More

Funding

other

Members involved

Main investigators

Pr Bart LEROY

Representative

Belgium

Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

Others investigators

Pr Elfride DE BAERE

Substitute

Belgium

Genetic Diagnostics (TWG6), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

ERN EYE member investigating site

HCP : Principal investigators